ADHD: Neuropharmacology study
1. Molecular pharmacology: Stimulants (methylphenidate and amphetamines) increase levels of
norepinephrine and dopamine by facilitating their release in the
prefrontal cortex. Methylphenidate binds to the dopamine transporter and
blocks the reuptake of dopamine from the synaptic cleft, whereas
amphetamines increase the availability of norepinephrine and dopamine at
the synaptic cleft by displacing them from the pre-synaptic terminal
storage sites and by blocking the action of a degradative enzyme,
catechol-o-methyltransferase. REF 4. Pliszka S. Issues AWGoQ. Practice
parameter for the assessment and treatment of children and adolescents
with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46(7):894–921. [PubMed] [Google Scholar]
2 Behavioral pharmacology :After the medication wears off, their child becomes very irritable and aggressive. The nonstimulants lack a mechanism of action linked to the abuse potential and they lack the desirable effects (speed of action, stimulant feel) that make stimulants susceptible to NMU (NONMEDICAL USE). The data suggest that ADHD
medication misuse and diversion are common health care problems for
stimulant medications, with the prevalence believed to be approximately
5% to 10% of high school students and 5% to 35% of college students,
depending on the study. Stimulant effectiveness and speed of action are
deemed desirable to enhance attention and focus performance for activities like studying, but stimulants are also misused recreationally.Ref:The potential for misuse and abuse of medications in ADHD: a review.
Comments
Post a Comment